glp 1 long term safety glp-1 long-term use The Trap: Your Jumpstart Might Be a Forever Commitment Your GLP-1 journey is unique, – Do NOT take a GLP1

Read clinical review Evidence-based guide to tirzepatide (Mounjaro) dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic differences, clinical trial subgroup data, and practical titration guidance

Your neurologist should evaluate your specific MS status, current medications, and disease activity before approving semaglutide or other GLP-1 treatments

JAMA Intern Med 2022

[6] Similarly, observational studies using healthcare databases have suggested that patients prescribed GLP-1 agonists for diabetes or obesity appear to have lower rates of alcohol-related hospital admissions and reduced self-reported drinking compared to those on other medications, though these findings are limited by potential confounding factors